Capricor Therapeutics Inc (CAPR) — Free Cash Flow Generation Index

Latest as of March 2023: 0.89x

Capricor Therapeutics Inc (CAPR) has a Free Cash Flow Generation Index of 0.89x as of March 2023. Free cash flow of $3.76 Million represents 1% of operating cash flow ($4.21 Million). Explore CAPR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.89x
Free Cash Flow / Operating CF

Free Cash Flow

$3.76 Million
USD

Operating Cash Flow

$4.21 Million
USD

Capital Expenditures

$453.12K
USD

Capricor Therapeutics Inc Free Cash Flow Generation Index (2014–2022)

Historical FCF Generation Index trend for Capricor Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see Capricor Therapeutics Inc (CAPR) cash conversion ratio.

Annual Free Cash Flow Generation for Capricor Therapeutics Inc (2014–2022)

Year-by-year Free Cash Flow Generation Index for Capricor Therapeutics Inc. Check Capricor Therapeutics Inc (CAPR) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.32x $1.56 Million $4.92 Million $3.36 Million ▼ -60.7%
2014 0.81x $772.13K $958.56K $186.43K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).